Ms contin and Remeron drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ms contin (morphine sulfate) and Remeron (mirtazapine). Common drug interactions include headache among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Ms contin and Remeron. It is created by eHealthMe based on reports of 305 people who take the same drugs from the FDA, and is updated regularly.
What is Ms contin?
Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.
What is Remeron?
Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,475 Remeron users. Check the latest studies of Remeron.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
305 people who take Ms contin and Remeron together, and have interactions are studied.
What are the common drug interactions of Ms contin and Remeron, by gender? *
What are the common drug interactions of Ms contin and Remeron, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ms contin and Remeron?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ms contin and Remeron:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ms contin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Remeron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ms contin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Remeron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on morphine sulfate and mirtazapine (the active ingredients of Ms contin and Remeron, respectively), and Ms contin and Remeron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lincocin and Lipitor - 9 seconds ago
- Could Cosentyx cause Lichen Sclerosus? - 11 seconds ago
- Oral Pain and drugs of ingredients of zoledronic acid - 18 seconds ago
- Drug interactions of Fidaxomicin and Ondansetron - 34 seconds ago
- Could Coumadin cause Eosinophil Count Increased? - 35 seconds ago
- Drug interactions of Vitamin B12 and Cozaar - 36 seconds ago
- Pantoprazole and Hepatic Steatosis for Women aged 40-49 - 47 seconds ago
- Policosanol vs. Colestipol Hydrochloride, side effect and effectiveness comparison - 49 seconds ago
- Cyclophosphamide and Moxifloxacin drug interactions for men aged 60+ - 50 seconds ago
- Prednisolone and Symbicort drug interactions for men aged 20-29 - a minute ago